Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation THT 2025

Subcutaneously Implanted Sensor for Remote Monitoring of Congestive Heart Failure Enables Effortless Capture of Electrocardiography and Three-Axis Acceleration Traces (ECG/SCG) Before and After Hospitalization: First Trend Results in Patients

Presenter: Marat Fudim

February 13, 2025

Presentation THT 2025

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Presenter: Kivanc Ozonat

February 12, 2025

Presentation THT 2025

Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange

Presenter: Midori Torpoco Rivera

February 12, 2025

Presentation THT 2025

Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort

Presenter: Anubodh Varshney

February 12, 2025

Presentation THT 2025

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2024

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Presenter: Liviu Klein

March 05, 2024

Presentation THT 2024

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Presenter: Gad Cotter

March 04, 2024

$Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?$

Presentation THT 2023

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Presenter: Michael Sutherland

March 21, 2023

Presentation THT 2023

Cardiovascular Hospitalization Rates in ATTR-CA: What Factors Make a Difference

Presenter: Margaret Cuomo

March 21, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

Presentation THT 2022

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Presenter: Akshay Desai

February 02, 2022

Presentation THT 2022

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Presenter: Shashank Sinha

February 02, 2022

Presentation THT 2022

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Presenter: Mohammed Al-Sadawi

February 01, 2022

Advertisement

Subcutaneously Implanted Sensor for Remote Monitoring of Congestive Heart Failure Enables Effortless Capture of Electrocardiography and Three-Axis Acceleration Traces (ECG/SCG) Before and After Hospitalization: First Trend Results in Patients

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange

Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Cardiovascular Hospitalization Rates in ATTR-CA: What Factors Make a Difference

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content